SIRT1激活减弱了C2C12肌肉细胞中的Palmitate诱导的亡
Gholamreza Taheripak1,2, Niusha Sabeti2,3, Naba Najar1,2
1Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Molecular biology reports
|February 24, 2024
概括
激活SIRT1可以对抗骨肌细胞中棕酸盐诱导的亡,改善线粒体生物发生和2型糖尿病中的胰岛素抵抗. 这项研究突出了SIRT1的功能.
科学领域:
- 细胞生物学 细胞生物学
- 代谢疾病 代谢疾病
- 分子生物学分子生物学
背景情况:
- 2型糖尿病涉及胰岛素抵抗,主要在骨肌肉中.
- 赛尔图因1 (SIRT1) 与胰岛素信号通路有关.
- 在Palmitate诱导的亡中SIRT1的确切作用需要进一步阐明.
研究的目的:
- 研究SIRT1在骨肌细胞中palmitate诱导的亡中的作用.
- 确定激活SIRT1是否可以减轻Palmitate诱导的胰岛素耐药性和亡.
主要方法:
- C2C12骨肌细胞用palmitate进行治疗,以诱导胰岛素抵抗.
- 在Palmitate诱导的亡期间,监测SIRT1表达水平.
- 评估了SIRT1激活和抑制对亡,线粒体生物发生和活性氧物种 (ROS) 的影响.
主要成果:
- 帕尔米酸诱导的亡降低了SIRT1的调节,并通过减少PGC-1抑制了线粒体生物发生.
- SIRT1过度表达增强了线粒体生物发生,而SIRT1抑制剂sirtinol降低了它.
- 棕酸治疗增加了ROS水平,ROS抑制剂和通过增强SIRT1表达来减轻ROS水平,从而抑制了亡.
结论:
- 激活SIRT1可以改善2型糖尿病的胰岛素抵抗.
- SIRT1减轻了脂质亡,并增强了骨肌细胞中的线粒体生物发生.
- 向SIRT1可能为2型糖尿病提供治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K


